Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name CD19/CD22 CAR T cells
Trade Name
Synonyms Autologous CD19/CD22 Chimeric Antigen Receptor T-cells
Drug Descriptions

CD19/CD22 CAR T cells are human T-cells engineered to express a CD19 and CD22 chimeric receptor, which may lead to cytotoxic immune response against tumor cells expressing CD19 and CD22 (PMID: 32005917).

DrugClasses CD22 Immune Cell Therapy 10
CAS Registry Number NA
NCIT ID C142834


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
CD19/CD22 CAR T cells CD19/CD22 CAR T cells 0 5
CD19/CD22 CAR T cells + Cyclophosphamide + Fludarabine CD19/CD22 CAR T cells Cyclophosphamide Fludarabine 0 0

Additional content available in CKB BOOST